Publication | Closed Access

Treatment with NAD + inhibited experimental autoimmune encephalomyelitis by activating AMPK/SIRT1 signaling pathway and modulating Th1/Th17 immune responses in mice

InflammationTh1/th17 Immune ResponsesAutoimmune DiseaseImmune RegulationAutophagyImmunologyExperimental Autoimmune EncephalomyelitisAutoimmunityImmunologic DiseaseInnate ImmunityImmunopathologyImmunotherapyMedicineCell Biology